Cansortium Inc. (OTCMKTS:CNTMF – Get Free Report) was the target of a significant growth in short interest during the month of December. As of December 15th, there was short interest totaling 177,286 shares, a growth of 243.3% from the November 30th total of 51,643 shares. Based on an average daily volume of 1,688,891 shares, the days-to-cover ratio is presently 0.1 days. Based on an average daily volume of 1,688,891 shares, the days-to-cover ratio is presently 0.1 days.
Cansortium Stock Performance
Cansortium stock opened at $0.04 on Friday. The company’s 50-day moving average price is $0.05 and its 200-day moving average price is $0.06. Cansortium has a twelve month low of $0.04 and a twelve month high of $0.10.
About Cansortium
Cansortium, Inc (OTCMKTS:CNTMF) is a vertically integrated cannabis company engaged in the cultivation, manufacturing, distribution and retail of medical cannabis products in the United States. The company’s operations span from seed to sale, with dedicated cultivation facilities, extraction labs and a network of dispensaries serving registered patients.
Cansortium holds licenses and operates in multiple jurisdictions, including Florida, Pennsylvania, Louisiana, Texas and Puerto Rico. Its product portfolio encompasses cannabis flower, pre-rolls, concentrates, vape cartridges, oils, edibles and topicals, offered under brands such as The+Source, Chroma and Campfire, alongside its private-label formulations.
Founded in 2017 and headquartered in Miami, Cansortium began dispensary operations in Florida in 2018 and has since expanded its footprint into new markets.
Further Reading
- Five stocks we like better than Cansortium
- Do not delete, read immediately
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- Can Any Expenses Be Deducted From Capital Gains Tax?
- Do you know what Amazon is planning for January 1?
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Cansortium Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cansortium and related companies with MarketBeat.com's FREE daily email newsletter.
